Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (61-70 of 315) with videos related to

Pageof 32
Sort By:
Leukemia|January 1, 1991
Will doxorubicin-containing regimens replace MOPP and its variants?G P Canellos, W Rosenberg
The New England Journal of Medicine|May 3, 2002
Long-term follow-up of Hodgkin's disease trialGeorge P Canellos, Donna Niedzwiecki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?George P Canellos, Peter Mauch
Cancer|April 1, 1980
Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexateT Ervin, G P Canellos
Current Hematologic Malignancy Reports|April 20, 2011
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?Gregory M Cote, George P Canellos
Seminars in Oncology|September 1, 1985
Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entityG P Canellos, J D Griffin
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaGeorge P Canellos, Ann S LaCasce
Tumori|March 23, 2016
Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni BonadonnaVincent T DeVita, George P Canellos
The New England Journal of Medicine|January 3, 1980
Cancer of the breast: the past decade (first of two parts)I C Henderson, G P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the targetC L Loprinzi, G P Canellos
Pageof 32

Showing results (61-70 of 315) with videos related to

Sort By:
Pageof 32
Leukemia|January 1, 1991
Will doxorubicin-containing regimens replace MOPP and its variants?G P Canellos, W Rosenberg
The New England Journal of Medicine|May 3, 2002
Long-term follow-up of Hodgkin's disease trialGeorge P Canellos, Donna Niedzwiecki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?George P Canellos, Peter Mauch
Cancer|April 1, 1980
Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexateT Ervin, G P Canellos
Current Hematologic Malignancy Reports|April 20, 2011
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?Gregory M Cote, George P Canellos
Seminars in Oncology|September 1, 1985
Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entityG P Canellos, J D Griffin
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaGeorge P Canellos, Ann S LaCasce
Tumori|March 23, 2016
Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni BonadonnaVincent T DeVita, George P Canellos
The New England Journal of Medicine|January 3, 1980
Cancer of the breast: the past decade (first of two parts)I C Henderson, G P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the targetC L Loprinzi, G P Canellos
Pageof 32